FMI Reveals Biomarker-driven Breakthroughs! Companion Diagnostic Tests Unlock Precision Treatment with PARP Inhibitors. The Industry Projected to surpass US$ 16,153.50 million by 2034 NEWARK, Del, March 20, 2024 (GLOBE NEWSWIRE) -- The PARP inhibitor market is anticipated to be worth US$ 6,279.90 million in 2024. The adoption of PARP inhibitors is likely to rise at a CAGR of...

PARP Inhibitor Market to Surpass USD 67.0 Billion by 2034, with 18.30% CAGR and Redefining Cancer Treatment Landscape - By PMI Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the PARP Inhibitor Market size was valued at about USD 12.5 Billion in 2024 and expected to grow at CAGR of 18.30%...

Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment Pune, India, July 22, 2020 (GLOBE NEWSWIRE) -- Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period....